Autoimmunity, Clonal Hematopoiesis, and Myeloid Neoplasms.

Rheum Dis Clin North Am

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Mayo Building, East 10, 200 First Street Southwest, Rochester, MN 55905, USA. Electronic address:

Published: August 2020

Clonal hematopoiesis has been linked with the development of hematologic malignancy and atherosclerotic cardiovascular disease; however, the association with autoimmune diseases remains to be defined. The link between autoimmune diseases and myeloid neoplasms (MNs) is complex, often multifactorial, and seems bidirectional. The limited data suggest an increased risk of MNs in rheumatoid arthritis and systemic lupus erythematosus. Paraneoplastic manifestations of MN include arthritis, vasculitis, and connective tissue disease. Treatment options for autoimmune disease such as cyclophosphamide and azathioprine have been associated with MNs, whereas the data for methotrexate and tumor necrosis factor inhibitors are equivocal.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2020.03.001DOI Listing

Publication Analysis

Top Keywords

clonal hematopoiesis
8
myeloid neoplasms
8
autoimmune diseases
8
autoimmunity clonal
4
hematopoiesis myeloid
4
neoplasms clonal
4
hematopoiesis linked
4
linked development
4
development hematologic
4
hematologic malignancy
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!